SUPERSTRING CAPITAL MANAGEMENT LP
Top Portfolio Positions
35 positions ·
$139,969,950 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
892,873 | $16,928,872 | 12.09% | |
| IMVT |
Immunovant, Inc.
Healthcare
|
357,606 | $8,882,933 | 6.35% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
225,158 | $8,666,331 | 6.19% | |
| SVRA |
Savara Inc
Healthcare
|
1,585,977 | $8,659,434 | 6.19% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
387,371 | $6,964,930 | 4.98% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
351,461 | $6,642,612 | 4.75% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
730,548 | $6,545,710 | 4.68% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
110,454 | $6,418,481 | 4.59% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
180,048 | $5,711,122 | 4.08% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
141,024 | $5,653,652 | 4.04% |
Portfolio Trend
10 quarters · across all stocks
Holdings in CABA
Shares Held
Position Value (USD)
9 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,868,182 | 1,066,239 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,935,274 | 2,253,550 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,614,188 | 1,544,525 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,612,361 | 1,060,764 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $635,676 | 458,972 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,866,605 | 822,293 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $622,072 | 131,795 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,046,414 | 139,895 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,960,996 | 290,797 | Shares | Sole | 2024-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||